Blueprint Medicines' Growth With AYVAKIT And Next-Gen Oncology Drugs
Blueprint Medicines' AYVAKIT leads its revenue growth, while its pipeline targets multiple cancers. Read why BPMC stock is a ...
Science Daily3h
Exposure to marijuana in the womb may increase risk of addiction to opioids later in life, study finds
Evidence has been growing to suggest that tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, poses risks to the developing fetus by impacting brain development. Now a new ...
BioPharma Dive5h
How a Biogen drug set the stage for a new biotech targeting ALS
Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke ...
BioPharma Dive6h
‘Find any advantage’: 3 biotech leaders on driving R&D success
Many companies just iterate indefinitely without ever making progress toward an actual drug,” said one biotech VC on a panel ...
FDA grants orphan drug designation to potential treatment of STXBP1 developmental and epileptic encephalopathy
Research that was carried out by Baylor College of Medicine and Texas Children's Hospital doctors has led to the U.S. Food ...
FierceBiotech11h
Biotechs behind J&J-bought Yellow Jersey partner on another immunology asset
The two companies have been working together since 2017, and, in 2021, they agreed to collaborate on NM26, a bispecific ...